Association between heart rate variability and haemodynamic response to exercise in chronic heart failure

References

• Ponikowski P, Voors AA, Anker SD. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37:2129–2200.
   PubMed Web of Science ®Google Scholar
• Leimbach WN, Wallin BG, Victor RG, et al. Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure. Circulation 1986;73:913–919.
   PubMed Web of Science ®Google Scholar
• Nolan J, Flapan AD, Capewell S, et al. Decreased cardiac parasympathetic activity in chronic heart failure and its relation to left ventricular function. Brit Heart J. 1992;67:482–485.
   PubMedGoogle Scholar
• Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation 1996;93:1043–1065.
   PubMed Web of Science ®Google Scholar
• Bilchick KC, Fetics B, Djoukeng R, et al. Prognostic value of heart rate variability in chronic congestive heart failure (Veterans Affairs’ Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure). Am J Cardiol. 2002;90:24–28.
   PubMed Web of Science ®Google Scholar
• La Rovere MT, Pinna GD, Maestri R, et al. Short-term heart rate variability strongly predicts sudden cardiac death in chronic heart failure patients. Circulation 2003;107:565–570.
   PubMed Web of Science ®Google Scholar
• La Rovere MT, Pinna GD, Maestri R, et al. Autonomic markers and cardiovascular and arrhythmic events in heart failure patients: still a place in prognostication? Data from the GISSI-HF trial. Eur J Heart Fail. 2012;14:1410–1419.
   PubMed Web of Science ®Google Scholar
• Nolan J, Batin PD, Andrews R, et al. Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart). Circulation 1998;98:1510–1516.
   PubMed Web of Science ®Google Scholar
• Cygankiewicz I, Zareba W, Vazquez R, et al. Risk stratification of mortality in patients with heart failure and left ventricular ejection fraction >35%. Am J Cardiol. 2009;103:1003–1010.
   PubMed Web of Science ®Google Scholar
• Musialik-Łydka A, Sredniawa B, Pasyk S. Heart rate variability in heart failure. Kardiol Pol. 2003;58:10–16.
   PubMedGoogle Scholar
• Tan LB. Cardiac pumping capability and prognosis in heart failure. Lancet. 1986;2:1360–1363.
   PubMed Web of Science ®Google Scholar
• Cotter G, Williams SG, Vered Z, et al. Role of cardiac power in heart failure. Curr Opin Cardiol. 2003;18:215–222.
   PubMed Web of Science ®Google Scholar
• Williams SG, Cooke GA, Wright DJ, et al. Peak exercise cardiac power output; a direct indicator of cardiac function strongly predictive of prognosis in chronic heart failure. Eur Heart J. 2001;22:1496–1503.
   PubMed Web of Science ®Google Scholar
• Lang CC, Karlin P, Haythe J, et al. Peak cardiac power output, measured noninvasively, is a powerful predictor of outcome in chronic heart failure. Circ Heart Fail. 2009;2:33–38.
   PubMed Web of Science ®Google Scholar
• Sandercock GR, Bromley P, Brodie DA. Reliability of three commercially available heart rate variability instruments using short-term (5-min) recordings. Clin Physiol Funct Imaging. 2004;24:359–367.
   PubMed Web of Science ®Google Scholar
• Jakovljevic DG, George RS, Donovan G, et al. Comparison of cardiac power output and exercise performance in patients with left ventricular assist devices, explanted (recovered) patients, and those with moderate to severe heart failure. Am J Cardiol. 2010;105:1780–1785.
   PubMed Web of Science ®Google Scholar
• Jakovljevic DG, Yacoub MH, Schueler S, et al. Left ventricular assist device as a bridge to recovery for patients with advanced heart failure. J Am Coll Cardiol. 2017;69:1924–1933.
   PubMed Web of Science ®Google Scholar
• Jakovljevic DG, Nunan D, Donovan G, et al. Comparison of cardiac output determined by different rebreathing methods at rest and at peak exercise. Eur J Appl Physiol. 2008;102:593–599.
   PubMed Web of Science ®Google Scholar
• Okwose NC, Zhang J, Chowdhury S, et al. Reproducibility of inert gas rebreathing method to estimate cardiac output at rest and during cardiopulmonary exercise stress testing. Int J Sports Med. 2019;40:125–132.
   PubMed Web of Science ®Google Scholar
• Jakovljevic DG, Seferovic PM, Nunan D, et al. Reproducibility of cardiac power output and other cardiopulmonary exercise indices in patients with chronic heart failure. Clin Sci. 2012;122:175–181.
   PubMed Web of Science ®Google Scholar
• Jakovljevic DG, Nunan D, Donovan G, et al. Lack of agreement between gas exchange variables measured by two metabolic systems. J Sports Sci Med. 2008;7:15–22.
   PubMed Web of Science ®Google Scholar
• Meaney E, Alva F, Moguel R, et al. Formula and nomogram for the sphygmomanometric calculation of the mean arterial pressure. Heart. 2000;84:64–64.
   PubMed Web of Science ®Google Scholar
• Mendoza DD, Cooper HA, Panza JA. Cardiac power output predicts mortality across a broad spectrum of patients with acute cardiac disease. Am Heart J. 2007;153:366–370.
   PubMed Web of Science ®Google Scholar
• Jakovljevic DG, Birks EJ, George RS, et al. Relationship between peak cardiac pumping capability and selected exercise-derived prognostic indicators in patients treated with left ventricular assist devices. Eur J Heart Fail. 2011;13:992–999.
   PubMed Web of Science ®Google Scholar
• Sanderson JE. Heart rate variability in heart failure. Heart Fail Rev. 1998;2:235–244.
   Google Scholar
• Chua TP, Ponikowski PP, Harrington D, et al. Contribution of peripheral chemoreceptors to ventilation and the effects of their suppression on exercise tolerance in chronic heart failure. Heart. 1996;76:483–489.
   PubMed Web of Science ®Google Scholar
• Ponikowski P, Chua TP, Piepoli M, et al. Ventilatory response to exercise correlates with impaired heart rate variability in patients with chronic congestive heart failure. Am J Cardiol. 1998;82:338–344.
   PubMed Web of Science ®Google Scholar
• Florea VG, Mareyev VY, Achilov AA, et al. Central and peripheral components of chronic heart failure: determinants of exercise tolerance. Int J Cardiol. 1999;70:51–56.
   PubMed Web of Science ®Google Scholar
• Calbet JA, Lundby C. Skeletal muscle vasodilatation during maximal exercise in health and disease. J Physiol. 2012;590:6285–6296.
   PubMed Web of Science ®Google Scholar
• Del Torto A, Corrieri N, Vignati C, et al. Contribution of central and peripheral factors at peak exercise in heart failure patients with progressive severity of exercise limitation. Int J Cardiol. 2017;248:252–256.
   PubMed Web of Science ®Google Scholar
• McCoy J, Bates M, Eggett C, et al. Pathophysiology of exercise intolerance in chronic diseases: the role of diminished cardiac performance in mitochondrial and heart failure patients. Open Heart. 2017;4:e000632.
   PubMed Web of Science ®Google Scholar
• Copie X, Pousset F, Lechat P, et al. Effects of beta-blockade with bisoprolol on heart rate variability in advanced heart failure: analysis of scatterplots of R-R intervals at selected heart rates. Am Heart J. 1996;132:369–375.
   PubMed Web of Science ®Google Scholar
• Binkley PF, Haas GJ, Starling RC, et al. Sustained augmentation of parasympathetic tone with angiotensin-converting enzyme inhibition in patients with congestive heart failure. J Am Coll Cardiol. 1993;21:655–661.
   PubMed Web of Science ®Google Scholar
• Korkmaz ME, Müderrisoğlu H, Uluçam M, et al. Effects of spironolactone on heart rate variability and left ventricular systolic function in severe ischemic heart failure. Am J Cardiol. 2000;86:649–653.
   PubMed Web of Science ®Google Scholar